Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results

The research conducted in this preclinical study assesses QazCovid-live, a live attenuated COVID-19 vaccine created in Kazakhstan, by conducting preclinical evaluations of safety, immunogenicity, and allergenicity in various animal models, including mice, rats, hamsters, and guinea pigs. The vaccine...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym Tussipova, Gulzhan Zhapparova, Talshyngul Tlenchiyeva, Karina Bissenbayeva, Kuanysh Zhapar, Kuandyk Zhugunissov, Sergazy Nurabayev, Aslan Kerimbayev
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Subjects:	QazCOVID-live live attenuated vaccine SARS-CoV-2 COVID-19 prevention preclinical study vaccine safety
Online Access:	https://www.mdpi.com/2076-393X/12/12/1401